BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 23980058)

  • 1. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
    Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
    Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway.
    Wang D; Wang W; Liang Q; He X; Xia Y; Shen S; Wang H; Gao Q; Wang Y
    J Ovarian Res; 2018 Jan; 11(1):6. PubMed ID: 29321035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
    Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
    Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome.
    Zhang C; Ma J; Wang W; Sun Y; Sun K
    Hum Reprod; 2018 Nov; 33(11):2096-2106. PubMed ID: 30272163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.
    Misugi T; Ozaki K; El Beltagy K; Tokuyama O; Honda K; Ishiko O
    Gynecol Obstet Invest; 2006; 61(4):208-15. PubMed ID: 16479139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone.
    Sander V; Luchetti CG; Solano ME; Elia E; Di Girolamo G; Gonzalez C; Motta AB
    Reproduction; 2006 Mar; 131(3):591-602. PubMed ID: 16514202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway
    Zhou J; Tan Y; Wang X; Zhu M
    Aging (Albany NY); 2021 Feb; 13(5):7084-7095. PubMed ID: 33638949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dehydroepiandrosterone on in vivo ovine follicular development.
    Narkwichean A; Jayaprakasan K; Maalouf WE; Hernandez-Medrano JH; Pincott-Allen C; Campbell BK
    Hum Reprod; 2014 Jan; 29(1):146-54. PubMed ID: 24256992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.
    Bas D; Abramovich D; Hernandez F; Tesone M
    Cell Biol Int; 2011 May; 35(5):423-9. PubMed ID: 21062263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
    Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
    Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intervention effect of Rosiglitozone in ovarian fibrosis of PCOS rats.
    Miao ZL; Guo L; Wang YX; Cui R; Yang N; Huang MQ; Qin WB; Chen J; Li HM; Wang ZN; Wei XC
    Biomed Environ Sci; 2012 Feb; 25(1):46-52. PubMed ID: 22424626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
    Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
    Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of γ-linolenic acid on Polycystic Ovary Syndrome associated Focal Segmental Glomerulosclerosis via TGF-β pathway.
    D Prabhu Y; Bhati M; Vellingiri B; Valsala Gopalakrishnan A
    Life Sci; 2021 Jul; 276():119456. PubMed ID: 33811895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study.
    Fulghesu AM; Romualdi D; Di Florio C; Sanna S; Tagliaferri V; Gambineri A; Tomassoni F; Minerba L; Pasquali R; Lanzone A
    Hum Reprod; 2012 Oct; 27(10):3057-66. PubMed ID: 22786777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
    Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
    Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice.
    Elia E; Sander V; Luchetti CG; Solano ME; Di Girolamo G; Gonzalez C; Motta AB
    Mol Hum Reprod; 2006 Aug; 12(8):475-81. PubMed ID: 16809378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS.
    Li X; Lin Y; Cheng X; Yao G; Yao J; Hu S; Zhu Q; Wang Y; Ding Y; Lu Y; Qi J; Zhao H; Bian X; Du Y; Sun K; Vankelecom H; Sun Y
    Hum Reprod Open; 2024; 2024(2):hoae013. PubMed ID: 38550897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
    Rababa'h AM; Matani BR; Ababneh MA
    Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoandrogenism in association with diminished functional ovarian reserve.
    Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.